[Functional activity of the alpha1-proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema]
- PMID: 2788886
[Functional activity of the alpha1-proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema]
Abstract
Pulmonary emphysema is thought to be due to an elastase-antielastase imbalance which leads to the destruction of alveolar walls. It is generally agreed that cigarette smoking is the major cause of acquired emphysema although many smokers fail to develop overt disease. Cigarette smoke inactivates alpha 1-proteinase inhibitor (alpha 1PI) which is believed to be the major antielastase in the lower respiratory tract. There is, however, controversy regarding the activity of alpha 1PI in smokers compared with nonsmokers. We, therefore, investigated the trypsin inhibitory capacity (TIC), the pancreatic elastase inhibitory capacity (PEIC), and the amount of immunoreactive alpha 1PI in serum and bronchoalveolar lavage fluid (BALF) of 24 individuals (15 smokers, 5 former smokers, 4 non-smokers) with clinical signs of emphysema and 32 persons (15 smokers, 6 former smokers, 11 non-smokers) without emphysema. Pancreatic elastase is known to be inhibited only by non-oxidised alpha 1PI whereas trypsin is inhibited by both native and oxidised alpha 1PI. Serum values of TIC/alpha 1PI and PEIC/alpha 1PI did not differ between the groups of subjects with emphysema (TIC/alpha 1PI: 0.71 +/- 0.12; PEIC/alpha 1PI: 0.44 +/- 0.06) and without emphysema (TIC/alpha 1PI: 0.68 +/- 0.13; PEIC/alpha 1PI: 0.41 +/- 0.07). Both serum-inhibitory capacities were found to be smaller than unit (= 1) indicating inactivation of alpha 1PI. BALF values of TIC/alpha 1PI showed a wide variation. TIC/alpha 1PI was greater than unity in 84% of subjects with emphysema (2.06 +/- 1.28) compared to 61% without emphysema (1.14 +/- 1.07) providing evidence for the presence of additional inhibitor(s) in those lavage fluids.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Alpha 1-proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema.Clin Investig. 1992 Mar-Apr;70(3-4):269-76. doi: 10.1007/BF00184661. Clin Investig. 1992. PMID: 1521041
-
[Trypsin and pancreatic elastase-inhibitory capacity of serum and bronchoalveolar lavage fluid of smokers, ex-smokers and nonsmokers].Pneumologie. 1990 Feb;44 Suppl 1:267-8. Pneumologie. 1990. PMID: 2367387 German.
-
The antielastase screen of the lower respiratory tract of alpha 1-proteinase inhibitor-sufficient patients with emphysema or pneumothorax.Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):880-3. doi: 10.1164/ajrccm/141.4_Pt_1.880. Am Rev Respir Dis. 1990. PMID: 2327650
-
Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.Int J Tuberc Lung Dis. 2008 Apr;12(4):361-7. Int J Tuberc Lung Dis. 2008. PMID: 18371259 Review.
-
Experimental studies on emphysema and chronic bronchial injury.Eur J Respir Dis Suppl. 1986;146:17-35. Eur J Respir Dis Suppl. 1986. PMID: 3536550 Review.
Cited by
-
Alpha 1-proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema.Clin Investig. 1992 Mar-Apr;70(3-4):269-76. doi: 10.1007/BF00184661. Clin Investig. 1992. PMID: 1521041